A transparent artificial intelligence framework to assess lung disease in pulmonary hypertension

Sci Rep. 2023 Mar 7;13(1):3812. doi: 10.1038/s41598-023-30503-4.

Abstract

Recent studies have recognized the importance of characterizing the extent of lung disease in pulmonary hypertension patients by using Computed Tomography. The trustworthiness of an artificial intelligence system is linked with the depth of the evaluation in functional, operational, usability, safety and validation dimensions. The safety and validation of an artificial tool is linked to the uncertainty estimation of the model's prediction. On the other hand, the functionality, operation and usability can be achieved by explainable deep learning approaches which can verify the learning patterns and use of the network from a generalized point of view. We developed an artificial intelligence framework to map the 3D anatomical models of patients with lung disease in pulmonary hypertension. To verify the trustworthiness of the framework we studied the uncertainty estimation of the network's prediction, and we explained the learning patterns of the network. Therefore, a new generalized technique combining local explainable and interpretable dimensionality reduction approaches (PCA-GradCam, PCA-Shape) was developed. Our open-source software framework was evaluated in unbiased validation datasets achieving accurate, robust and generalized results.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Artificial Intelligence
  • Humans
  • Hypertension, Pulmonary* / diagnostic imaging
  • Hypertension, Pulmonary* / etiology
  • Lung / diagnostic imaging
  • Lung Diseases* / complications
  • Lung Diseases* / diagnosis
  • Models, Anatomic
  • Radiographic Image Interpretation, Computer-Assisted*
  • Software
  • Tomography, X-Ray Computed / methods